Financial News
Latest News about BBIO
Recent news which mentions BBIO
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
November 19, 2024
From Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
From Motley Fool
BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
September 30, 2024
From Benzinga
From Benzinga
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
September 03, 2024
From Benzinga
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
August 30, 2024
From Benzinga
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday
August 30, 2024
From Benzinga
Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles
August 30, 2024
From Benzinga
Tickers
BBIO
From InvestorPlace
From Benzinga
The 3 Best Biotech Stocks to Buy in June 2024
June 05, 2024
From InvestorPlace
From Benzinga
Why BridgeBio Pharma Stock Is Trading Lower Tuesday
June 04, 2024
From Benzinga
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
From InvestorPlace
Tickers
BBIO
From InvestorPlace
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
From Benzinga
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
February 15, 2024
From Benzinga
3 Groundbreaking Biotech Stocks to Invest in Now
January 29, 2024
From InvestorPlace
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
January 22, 2024
From InvestorPlace
2 Biotechs That Could Get Bought Out in 2024
January 03, 2024
From Motley Fool
3 Russell 2000 Stocks That Are About to Get Absolutely Crushed
December 18, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
From Benzinga
Rare Disease Player BridgeBio Pharma's Upside Potential Is Significant According to Citi Analyst - Here's Why
November 07, 2023
Tickers
BBIO
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
